This invention is directed to a tetrahydro-indazole cannabinoid modulator compound of formula I: 1 and a method for use in treating, ameliorating or preventing a cannabinoid receptor mediated syndrome, disorder or disease.

 
Web www.patentalert.com

< Adamantylglycine-based inhibitors of dipeptidyl peptidase IV and methods

< Agonist and antagonist ligands of the nociceptin receptor

> 11-Beta hydroxysteroid dehydrogenase type 1 inhibitors as anti-obesity/anti-diabetes compounds and 17-beta hydrosteroid dehydrogenase type I inhibitors as useful agents for the treatment of cancers, especially breast cancer

> Substituted fused heterocyclic C-glycosides
~ 00214